Novogene Co., Ltd.

Novogene Co., Ltd.verified

688315.SS

Price:

$13.62

Market Cap:

$5.52B

Novogene Co., Ltd. provides genomic services and solutions worldwide. The company offers genomic solutions, such as human genome sequencing, gene regulation, single cell sequencing, animal and plant solutions, and microbial genome sequencing; and cancer genomic profiling, whole exome sequencing, and FFPE RNA sequencing, as well as clinical-grade whole exome sequencing services. It also provides NovoFocus, a next-generation sequencing based companion diagnostic assay for PARP inhibitor therapies; and NovoNeoantigen, a bioinformatics pipeline for the identification of cancer neoantigens with whole exome sequencing and whole transcriptome sequencing data from paired tumor-normal samples. Novoge...[Read more]

Industry

Biotechnology

IPO Date

2021-04-13

Stock Exchange

SHH

Ticker

688315.SS

The PE Ratio as of December 2025 (TTM) for Novogene Co., Ltd. (688315.SS) is 31.67

According to Novogene Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 31.67. This represents a change of -13.62% compared to the average of 36.66 of the last 4 quarters.

Novogene Co., Ltd. (688315.SS) Historical PE Ratio (quarterly & annually)

How has 688315.SS PE Ratio performed in the past?

The mean historical PE Ratio of Novogene Co., Ltd. over the last ten years is 154.26. The current 31.67 PE Ratio has changed 1.95% with respect to the historical average. Over the past ten years (40 quarters), 688315.SS's PE Ratio was at its highest in in the March 2018 quarter at 195.71. The PE Ratio was at its lowest in in the June 2020 quarter at -185.67.

Quarterly (TTM)
Annual

Average

154.26

Median

98.71

Minimum

26.04

Maximum

442.36

Novogene Co., Ltd. (688315.SS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Novogene Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 212.78%

Maximum Annual PE Ratio = 442.36

Minimum Annual Increase = -75.54%

Minimum Annual PE Ratio = 26.04

Quarterly (TTM)
Annual
YearPE RatioChange
202426.04-48.82%
202350.89-14.61%
202259.59-18.81%
202173.39-75.54%
2020300.10212.78%
201995.95-5.45%
2018101.48-18.52%
2017124.55-53.57%
2016268.22-39.36%

Novogene Co., Ltd. (688315.SS) Average PE Ratio

How has 688315.SS PE Ratio performed in the past?

The current PE Ratio of Novogene Co., Ltd. (688315.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

45.51

5-year avg

102.00

10-year avg

154.26

Novogene Co., Ltd. (688315.SS) PE Ratio vs. Peers

How is 688315.SS’s PE Ratio compared to its peers?

Novogene Co., Ltd.’s PE Ratio is greater than Hangzhou Biotest Biotech Co.,Ltd. (0), less than Jiangxi Fushine Pharmaceutical Co., Ltd. (37.49), greater than Xiangxue Pharmaceutical Co.,Ltd. (-27.49), greater than Assure Tech (Hangzhou) Co., Ltd. (-6.04), less than Beijing Kawin Technology Share-Holding Co., Ltd. (41.51), greater than Pulike Biological Engineering, Inc. (30.85), greater than Qingdao NovelBeam Technology Co.,Ltd. (30.61), less than Jiangsu Aidea Pharmaceutical Co., Ltd. (36.60), greater than GuiZhou SanLi Pharmaceutical Co.,Ltd (-83.69), greater than null (29.69),

Build a custom stock screener for Novogene Co., Ltd. (688315.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novogene Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Novogene Co., Ltd. (688315.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Novogene Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Novogene Co., Ltd.'s PE Ratio?

How is the PE Ratio calculated for Novogene Co., Ltd. (688315.SS)?

What is the highest PE Ratio for Novogene Co., Ltd. (688315.SS)?

What is the 3-year average PE Ratio for Novogene Co., Ltd. (688315.SS)?

What is the 5-year average PE Ratio for Novogene Co., Ltd. (688315.SS)?

How does the current PE Ratio for Novogene Co., Ltd. (688315.SS) compare to its historical average?